Gerber, David E.
Beg, M. Shaalan
Fattah, Farjana
Frankel, Arthur E.
Fatunde, Oluwatomilade
Arriaga, Yull
Dowell, Jonathan E.
Bisen, Ajit
Leff, Richard D.
Meek, Claudia C.
Putnam, William C.
Kallem, Raja Reddy
Subramaniyan, Indhumathy
Dong, Ying
Bolluyt, Joyce
Sarode, Venetia
Luo, Xin
Xie, Yang
Schwartz, Brian
Boothman, David A.
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (K24CA201543-01, 1P30CA142543-01, 1P30CA142543-03)
Cancer Prevention and Research Institute of Texas (RP170003)
ArQuol Inc
Article History
Received: 3 April 2018
Revised: 23 August 2018
Accepted: 4 September 2018
First Online: 15 October 2018
Ethics approval and consent to participate
: This study was approved by the UT Southwestern Institutional Review Board (IRB # STU 042011–005). All patients provided informed consent. The study was performed in accordance with the Declaration of Helsinki.
: D.E.G. has received research funding from ArQule, Inc. B.S. is an employee of ArQule, Inc. The other authors declare no competing interests.
: This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).